Bioventus Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $568.1 | $573.3 | $512.3 | $512.1 | $430.9 |
| Operating income | $54.0 | -$15.2 | -$81.7 | -$167.2 | $12.1 |
| Net income | $22.7 | -$36.1 | -$156.2 | -$158.7 | $19.4 |
| Cash Flow Statement | |||||
| Free cash flow | $72.1 | $37.8 | $8.0 | -$15.0 | $9.5 |
Shares outstanding 83.5M · Free float 19.2%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.